MedTrace Logo

Pilot Study on Botulinum Toxin B as Treatment for Hidradenitis Suppurativa

NCT03103074 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2018-10-25

No results posted yet for this study

Summary

Randomized double blind placebo controlled pilot study/proof of concept-study to see if intradermal injection with Botulinum toxin B is an effective treatment of Hidradenitis suppurativa

Conditions

Interventions

DRUG

Botulinum B Toxin

Intradermal injections

OTHER

Placebo Saline

Intradermal injections

Sponsors & Collaborators

  • The Royal Norwegian Ministry of Health

    collaborator OTHER

  • Hidrosis Clinic, Stockholm, Sweden

    collaborator OTHER

  • University Hospital of North Norway

    lead OTHER

Principal Investigators

  • Øystein Grimstad, MD PhD · Consultant NEHR-HUD/Postdoc

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2018-03-23
Completion
2018-09-23

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03103074 on ClinicalTrials.gov